These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23915185)

  • 21. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
    Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
    Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
    Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
    Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
    J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
    Song Y; Xu X; Wang N; Zhang T; Hu C
    J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
    Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
    Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis.
    Cui JF; Liu YK; Zhou HJ; Kang XN; Huang C; He YF; Tang ZY; Uemura T
    World J Gastroenterol; 2008 Feb; 14(8):1257-62. PubMed ID: 18300354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hepatocellular carcinoma using glycomic analysis.
    Goldman R; Ressom HW; Varghese RS; Goldman L; Bascug G; Loffredo CA; Abdel-Hamid M; Gouda I; Ezzat S; Kyselova Z; Mechref Y; Novotny MV
    Clin Cancer Res; 2009 Mar; 15(5):1808-13. PubMed ID: 19223512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.
    Göbel T; Vorderwülbecke S; Hauck K; Fey H; Häussinger D; Erhardt A
    World J Gastroenterol; 2006 Dec; 12(47):7604-12. PubMed ID: 17171788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
    Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
    Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.
    Liu C; Shen J; Pan C; Yang L; Mou S; Wang H; Liang Y
    Am J Clin Pathol; 2010 Aug; 134(2):235-41. PubMed ID: 20660326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum peptide profiling: identifying novel cancer biomarkers for early disease detection.
    Martorella A; Robbins R
    Acta Biomed; 2007; 78 Suppl 1():123-8. PubMed ID: 17465330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS.
    Cao Y; He K; Cheng M; Si HY; Zhang HL; Song W; Li AL; Hu CJ; Wang N
    Biomed Res Int; 2013; 2013():814876. PubMed ID: 23509784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma.
    An Y; Bekesova S; Edwards N; Goldman R
    Dis Markers; 2010; 29(1):11-20. PubMed ID: 20826913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification.
    Camaggi CM; Zavatto E; Gramantieri L; Camaggi V; Strocchi E; Righini R; Merina L; Chieco P; Bolondi L
    Clin Chem Lab Med; 2010 Sep; 48(9):1319-26. PubMed ID: 20509833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
    Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
    J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers.
    Ressom HW; Varghese RS; Goldman L; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Goldman R
    Pac Symp Biocomput; 2008; ():216-27. PubMed ID: 18229688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
    Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
    J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.